Jingwen Du

southern medical university - china

H指数:9

被引数:459

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of Oral Posaconazole on Venetoclax Plasma Concentration and its Efficacy in Patients with Acute Myeloid Leukemia

口服泊沙康唑对急性髓性白血病患者中维奈克拉血浆浓度及其疗效的影响

Recent Patents on Anti-Cancer Drug Discovery

IF4.1

2026-01-012

PRE

Neutrophils and neutrophil extracellular traps: double-edged swords in cancer pathophysiology and therapy resistance

中性粒细胞和中性粒细胞胞外陷阱：癌症病理生理学和治疗耐药性中的双刃剑

Cell Communication and Signaling

IF8.9

2025-11-040

OAAI

Identification of specific T-cell response and T-cell receptor targeting shared neoantigen for acute myeloid leukemia

鉴定针对急性髓系白血病共享新抗原的特异性T细胞反应及T细胞受体靶向研究

Blood Cancer Journal

IF11.6

2025-10-240

Microstructural evolution in 60Si2CrVNb spring steel induced by a novel quenching-partitioning-deep cryogenic treatment (Q-P-D) process

60Si2CrVNb弹簧钢在一种新型的淬火-分配-深冷处理(Q-P-D)工艺下引起的微观结构演变

Materials Today Communications

IF4.5

2025-10-050

PRE

Study on the Influence of Deformation and Temperature on the Properties of High-Strength Tungsten Alloy Wire

变形和温度对高强钨合金丝材性能影响的研究

micromachines

IF0

2025-08-100

Effects of Sc doping on microstructure and properties of high strength and high conductivity Cu-6 wt%Ag alloy wires with large section size for ultra-high pulsed magnet coils

Sc掺杂对超大截面尺寸高强高导Cu-6 wt % Ag合金丝组织与性能的影响

MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING

IF7

2025-04-010

PRE

Evaluation of Water Replenishment in the Northern Segment of the Yellow River Within the Beijing-Hangzhou Grand Canal, China

京杭大运河内黄河北段补水评价

WATER

IF3

2024-12-280

METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth

METTL3调控M6A甲基化修饰EBV-pri-miR-BART3-3p促进NK/T细胞淋巴瘤生长

CANCER LETTERS

IF10.1

2024-08-011

PRE

High strength and high ductility of 60Si2CrVAT spring steel through a novel quenching and partitioning (Q-P) process

MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING

IF7

2024-05-010

PRE

Clinical Manifestation, Risk Factors, and Immune Checkpoint Inhibitor Rechallenge of Checkpoint Inhibitor-Associated Pneumonitis in Patients With Lung Cancer

JOURNAL OF IMMUNOTHERAPY

IF2.9

2024-04-111

PRE

Immunotherapy for Tumor Metastasis by Artificial Antigen-Presenting Cells via Targeted Microenvironment Regulation and T-Cell Activation

通过靶向微环境调节和T细胞活化人工抗原呈递细胞对肿瘤转移的免疫治疗

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2021-11-1719

PRE

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

FRONTIERS IN IMMUNOLOGY

IF5.9

2020-11-2737

OAAI

Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2019-10-0216

OAAI

Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer

CANCER CELL INTERNATIONAL

IF6

2018-10-2287

OAAI

Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib

MOLECULAR CARCINOGENESIS

IF3.2

2018-04-2415

PREAI

Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8

MOLECULAR MEDICINE REPORTS

IF3.5

2015-04-237

OAAI

Novel oncoprotein EPS8: a new target for anticancer therapy

FUTURE ONCOLOGY

IF2.6

2013-10-0926

PREAI

Jingwen Du

个人简介

教育背景

工作经历

荣誉奖项

研究方向